News Focus
News Focus
icon url

DewDiligence

04/15/25 11:33 AM

#255107 RE: DewDiligence #248713

Biocon’s Eylea biosimilar will launch in US market in 2H26, pursuant to litigation settlement with REGN:

https://www.prnewswire.com/news-releases/biocon-biologics-secures-market-entry-date-for-yesafili-an-interchangeable-biosimilar-to-eylea-in-the-us-302428884.html